InChI=1S/C20H25N3S/c1- 21- 13- 15- 22(16- 14- 21) 11- 6- 12- 23- 17- 7- 2- 4- 9- 19(17) 24- 20- 10- 5- 3- 8- 18(20) 23/h2- 5,7- 10H,6,11- 16H2,1H3 |
WEYVCQFUGFRXOM-UHFFFAOYSA-N |
CN1CCN(CCCN2c3ccccc3Sc3ccccc23)CC1 |
|
Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
|
|
dopaminergic antagonist
A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
|
|
phenothiazine antipsychotic drug
dopaminergic antagonist
A drug that binds to but does not activate dopamine receptors, thereby blocking the actions of dopamine or exogenous agonists.
|
|
View more via ChEBI Ontology
10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine
|
10-(3-(4-Methyl-1-piperazinyl)propyl)-10H-phenothiazine
|
NIST Chemistry WebBook
|
N-(3-(4-Methyl-1-piperazinyl)propyl)phenothiazine
|
ChemIDplus
|
N-Methyl-piperazinyl-N'-propyl-phenothiazin
|
ChemIDplus
|
N-Methyl-piperazinylpropyl-phenothiazine
|
NIST Chemistry WebBook
|
Pernazine
|
ChemIDplus
|
298041
|
Gmelin Registry Number
|
Gmelin
|
39009
|
Reaxys Registry Number
|
Reaxys
|
84-97-9
|
CAS Registry Number
|
ChemIDplus
|
84-97-9
|
CAS Registry Number
|
NIST Chemistry WebBook
|
1650428
|
PubMed citation
|
Europe PMC
|
19904008
|
PubMed citation
|
Europe PMC
|
23479940
|
PubMed citation
|
Europe PMC
|
24425538
|
PubMed citation
|
Europe PMC
|
|